"First, do not harm": The case for Monitoring the Safety & Effectiveness of COVID-19 Vaccines and Vaccination
This blog was originally posted at the World Bank Group's Investing in Health site under the title "Monitoring the Safety & Effectiveness of COVID-19 Vaccines and Vaccination" on June 9, 2021: https://blogs.worldbank.org/health/monitoring-safety-effectiveness-covid-19-vaccines-and-vaccination?CID=WBW_AL_BlogNotification_EN_EXT
Huihui Wang, Albert Figueras & Patricio V.
*This blog was originally posted at the World Bank Group's Investing in Health site on May 30, 2021. See: https://blogs.worldbank.org/health/ominous-fact-world-no-tobacco-day-2021-smoking-kills-more-people-covid-19
Patricio V. Marquez
The Biden Administration recently announced that it is delaying until March 22, 2021 the application of the former administration’s drug regulation adopted in December 2020, that requires community health centers to pass on all their insulin and epinephrine discount savings to patients.
Patricio V. Marquez and Albert Figueras
As of mid-February 2021, the ongoing COVID-19 pandemic has resulted in more than 108 million confirmed cases and over 2.3 million deaths. The surging patient caseloads hospitalized or admitted to intensive care units (ICU) have pushed hospitals and ICU closer to 100% capacity in many countries, creating an extraordinary strain on resources and personnel and making quality-of-care standards harder to maintain.